Javanshir S

References (3)

Title : Isoindolinedione-Benzamide Pyridinium Derivatives for Targeting Alzheimer's Disease - Noori_2024_ACS.Omega_9_48032
Author(s) : Noori M , Khalili Ghomi M , Dastyafteh N , Oliyaei N , Hamedifar H , Javanshir S , Tanideh N , Sattarinezhad E , Sattari F , Haghani M , Rahmani H , Larijani B , Mahdavi M , Hajimiri MH , Iraji A
Ref : ACS Omega , 9 :48032 , 2024
Abstract :
PubMedSearch : Noori_2024_ACS.Omega_9_48032
PubMedID: 39676969

Title : Phenyl-quinoline derivatives as a lead structure of cholinesterase inhibitor endowed with potency to reduce the GSK-3beta level targeting Alzheimer's disease - Noori_2023_Int.J.Biol.Macromol__127392
Author(s) : Noori M , Dastyafteh N , Safapoor S , Ghomi MK , Tanideh R , Zomorian K , Hamedifar H , Dara M , Zare S , Irajie C , Javanshir S , Rastegar H , Panahi N , Larijani B , Mahdavi M , Hajimiri MH , Iraji A
Ref : Int J Biol Macromol , :127392 , 2023
Abstract :
PubMedSearch : Noori_2023_Int.J.Biol.Macromol__127392
PubMedID: 37827412

Title : New 4-phenylpiperazine-carbodithioate-N-phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and alpha-glucosidase enzymes - Mohammadi-Khanaposhtani_2022_Arch.Pharm.(Weinheim)__e2100313
Author(s) : Mohammadi-Khanaposhtani M , Nori M , Valizadeh Y , Javanshir S , Dastyafteh N , Moaazam A , Hosseini S , Larijani B , Adibi H , Biglar M , Hamedifar H , Mahdavi M , Kamci H , Karakus A , Taslimi P
Ref : Arch Pharm (Weinheim) , :e2100313 , 2022
Abstract :
PubMedSearch : Mohammadi-Khanaposhtani_2022_Arch.Pharm.(Weinheim)__e2100313
PubMedID: 35132681